BHMP
AZN icon

Bardin Hill Management Partners’s AstraZeneca AZN Stock Holding History

Bardin Hill Management Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,060
Closed -$1.22M – 97
2014
Q2 		$1.22M Buy
+3,060
New +$221K 0.07% 82

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bardin Hill Management Partners's AZN Position: Q3 2014 in Review

Bardin Hill Management Partners sold out of AstraZeneca (AZN) in Q3 2014, closing a stake of 251,864 shares — an estimated $18.7M sold.

Bardin Hill Management Partners first reported a position in AZN in Q2 2014 and held it in 1 quarter. The position peaked at $18.7M in Q2 2014. 402 funds tracked by Wall St. Rank hold AZN as of Q3 2014.

  • Bardin Hill Management Partners reported no remaining AstraZeneca position as of Q3 2014 after selling out during the quarter.
  • Bardin Hill Management Partners sold 251,864 AstraZeneca shares in Q3 2014, an estimated $18.7M.
  • Bardin Hill Management Partners first reported a position in AstraZeneca in Q2 2014 and held it in 1 quarter.
  • Bardin Hill Management Partners's AstraZeneca position peaked at $18.7M in Q2 2014.
  • 402 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2014.

Based on Bardin Hill Management Partners's 13F filing for Q3 2014, filed 14 Nov 2014.